Frost & Sullivan

presented by
Devices & Diagnostics

Cardiocom acquisition shows Medtronic is serious about expanding from devices to data

When Medtronic announced its acquisition of Cardiocom  earlier this week,  it was a big (and loud) move in shaping the company’s “now we’re a healthcare service provider”  strategy. But Cardiocom  only makes $40 to $50 million in revenue, relatively small potatoes for a titan like Medtronic. What does this announcement mean, really, then?  “The importance […]